1. Home
  2. Labeler Index
  3. Hospira, Inc.
  4. 0409-5779
  5. NDC Package Code: 0409-5779-01 Tpn Electrolytes

NDC Package 0409-5779-01 Tpn Electrolytes

Sodium Chloride,Calcium Chloride,Potassium Chloride,Magnesium Chloride,And Sodium Acetate - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0409-5779-01
Package Description:
25 VIAL, SINGLE-DOSE in 1 CARTON / 20 mL in 1 VIAL, SINGLE-DOSE (0409-5779-11)
Product Code:
0409-5779
Proprietary Name:
Tpn Electrolytes
Non-Proprietary Name:
Sodium Chloride, Calcium Chloride, Potassium Chloride, Magnesium Chloride, And Sodium Acetate Anhydrous
Substance Name:
Calcium Chloride; Magnesium Chloride; Potassium Chloride; Sodium Acetate Anhydrous; Sodium Chloride
Usage Information:
TPN Electrolytes (multiple electrolyte additive) is indicated for use as a supplement to nutritional solutions containing concentrated dextrose and amino acids delivered by central venous infusion, to help maintain electrolyte homeostasis in adult patients.
11-Digit NDC Billing Format:
00409577901
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 801451 - acetate 29.5 MEQ / calcium 4.5 MEQ / chloride 35 MEQ / magnesium 5 MEQ / potassium 20 MEQ / sodium 35 MEQ in 20 ML Injectable Solution
  • RxCUI: 801451 - calcium chloride 0.23 MEQ/ML / magnesium chloride 0.53 MEQ/ML / potassium chloride 0.1 MEQ/ML / sodium acetate 1.48 MEQ/ML / sodium chloride 0.27 MEQ/ML Injectable Solution
  • RxCUI: 801451 - Calcium Chloride 0.23 MEQ/ML / Magnesium Chloride 0.53 MEQ/ML / K+ Chloride 0.1 MEQ/ML / Sodium Acetate 1.48 MEQ/ML / NaCl 0.27 MEQ/ML Injectable Solution
  • RxCUI: 801451 - Calcium Chloride 0.23 MEQ/ML / Magnesium Chloride 0.53 MEQ/ML / Pot Chloride 0.1 MEQ/ML / Sodium Acetate 1.48 MEQ/ML / NaCl 0.27 MEQ/ML Injectable Solution
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Hospira, Inc.
    Dosage Form:
    Injection, Solution, Concentrate - A sterile preparation for parenteral use which, upon the addition of suitable solvents, yields a solution conforming in all respects to the requirements for Injections.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • CALCIUM CHLORIDE 331 mg/20mL
  • MAGNESIUM CHLORIDE 508 mg/20mL
  • POTASSIUM CHLORIDE 1491 mg/20mL
  • SODIUM ACETATE ANHYDROUS 2420 mg/20mL
  • SODIUM CHLORIDE 321 mg/20mL
    • Pharmacologic Class(es):
  • Blood Coagulation Factor - [EPC] (Established Pharmacologic Class)
  • Calcium - [CS]
  • Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
  • Cations, Divalent - [CS]
  • Increased Coagulation Factor Activity - [PE] (Physiologic Effect)
  • Increased Large Intestinal Motility - [PE] (Physiologic Effect)
  • Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
  • Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
  • Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
  • Osmotic Activity - [MoA] (Mechanism of Action)
  • Osmotic Laxative - [EPC] (Established Pharmacologic Class)
  • Phosphate Binder - [EPC] (Established Pharmacologic Class)
  • Phosphate Chelating Activity - [MoA] (Mechanism of Action)
  • Potassium Compounds - [CS]
  • Potassium Salt - [EPC] (Established Pharmacologic Class)
  • Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
    • Sample Package:
    No
    FDA Application Number:
    NDA018895
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    02-28-2005
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0409-5779-01?

    The NDC Packaged Code 0409-5779-01 is assigned to a package of 25 vial, single-dose in 1 carton / 20 ml in 1 vial, single-dose (0409-5779-11) of Tpn Electrolytes, a human prescription drug labeled by Hospira, Inc.. The product's dosage form is injection, solution, concentrate and is administered via intravenous form.

    Is NDC 0409-5779 included in the NDC Directory?

    Yes, Tpn Electrolytes with product code 0409-5779 is active and included in the NDC Directory. The product was first marketed by Hospira, Inc. on February 28, 2005 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0409-5779-01?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 0409-5779-01?

    The 11-digit format is 00409577901. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20409-5779-015-4-200409-5779-01